-E Frei Researcher Activity Profile

Research Author Detailed Information 

E Frei Publication Rate By Year

E Frei has published 1 paper(s) in 1960, 1 paper(s) in 1961, 4 paper(s) in 1962, 2 paper(s) in 1964, 1 paper(s) in 1966, 4 paper(s) in 1972, 2 paper(s) in 1973, 2 paper(s) in 1974, 2 paper(s) in 1975, 1 paper(s) in 1978, 1 paper(s) in 1981, 1 paper(s) in 1986, 1 paper(s) in 1990, 2 paper(s) in 2007, for a total of 25 research publications in total.

E E Frei Author Information

LAST NAME: frei

FIRST NAME: e

INITIALS: E

AFFILIATION:

Papers

E Frei's Publication Record

1. Improved serodiagnosis of alveolar echinococcosis of humans using an in vitro-produced Echinococcus multilocularis antigen. Year Published: 2007
Institute of Parasitology, University of Berne, Berne, Switzerland. nmueller@ipa.unibe.ch
2. Post-surgical follow-up (by ELISA and immunoblotting) of cured versus non-cured cystic echinococcosis in young patients. Year Published: 2007
University of Monastir, Faculty of Pharmacy, Department of Clinical Biology B, Laboratory of Parasitology and Mycology, 99UR/08-05 1- rue Avicenne, 5000 Monastir Tunisia.
3. Cytokinetic studies and treatment response in adult acute leukemia. Year Published: 1975
4. Limb preservation in osteogenic sarcoma: a preliminary report. Year Published: 1978
5. Preclinical rationale and phase I clinical trial of the adriamycin analog, AD 32. Year Published: 1981
6. Clinical and scientific considerations in preoperative (neoadjuvant) chemotherapy. Year Published: 1986
7. Dose response for adjuvant chemotherapy of breast cancer: experimental and clinical considerations. Year Published: 1990
Dana-Farber Cancer Institute, Boston, MA 02115.
8. A commentary. Selected considerations regarding chemotherapy as adjuvant in cancer treatment. Year Published: 1966
9. Dose-schedule studies with hydroxyurea (NSC-32065) in malignant melanoma. Year Published: 1972
10. Phase I and phototoxicity studies of pseudourea (NSC-56054). Year Published: 1972
11. The chemotherapy of human and animal acute leukemia. Year Published: 1972
12. Distribution and mechanism of clearance of L-asparaginase (NSC-109229). Year Published: 1972
13. 5-(3,3-dimethyl-1-triazeno)imidazole-4-carboxamide (NSC-45388) in the treatment of lymphoma. Year Published: 1973
14. Kinetic scheduling of vincristine (NSC-67574) and bleomycin (NSC-125066) in patients with lung cancer and other malignant tumors. Year Published: 1973
15. Selman A. Waksman Conference on actinomycins: their potential for cancer chemotherapy. Preface. Year Published: 1974
16. The clinical use of actinomycin. Year Published: 1974
17. Phase I. evaluation of cyclocytidine (NSC-145668). Year Published: 1975
18. Clinical studies of vinblastine. Year Published: 1961
19. Comparisons of activities of antitumor agents in selected human and rodent tumor systems. Year Published: 1962
20. Methylglyoxal bis (guanylhydrazone): a new agent active against acute myelocytic leukemia. Year Published: 1962
21. Summary of current information on 6-azauridine. Year Published: 1962
22. Treatment of meningeal leukemia with intrathecal aminopterin. Year Published: 1962
23. COMPARATIVE CLINICAL TOXICITY OF 6-MERCAPTOPURINE (NSC-755)-1 AND 6-MERCAPTOPURINE RIBONUCLEOSIDE (NSC-4911)-2 ADMINISTERED INTRAVENOUSLY TO PATIENTS WITH ADVANCED CANCER. Year Published: 1964
24. 6-THIOGUANINE (NSC-752)-1 THERAPY IN PATIENTS WITH MULTIPLE MYELOMA. Year Published: 1964
25. The effectiveness of 2-amino-6-[(1-methyl-4-nitro-5-imidazolyl)thio] purine against transplantable mouse leukemia. Year Published: 1960